Request Demo
Last update 20 Mar 2025
pp65 fl LAMP mRNA-LPs Vaccine(University of Florida)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Therapeutic vaccine, mRNA vaccine |
Synonyms RNA-LPs(University of Florida), pp65-shLAMP DC(University of Florida), pp65-shLAMP mRNA DCs(University of Florida) |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with pp65 fl LAMP mRNA-LPs Vaccine(University of Florida)NCT06389591
A Phase I Study of RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
NCT02465268
ATTAC-II: A Phase II Randomized, Blinded, and Placebo-controlled Trial of CMV RNA-Pulsed Dendritic Cells With Tetanus-Diphtheria Toxoid Vaccine in Patients With Newly-Diagnosed Glioblastoma
100 Clinical Results associated with pp65 fl LAMP mRNA-LPs Vaccine(University of Florida)
Login to view more data
100 Translational Medicine associated with pp65 fl LAMP mRNA-LPs Vaccine(University of Florida)
Login to view more data
100 Patents (Medical) associated with pp65 fl LAMP mRNA-LPs Vaccine(University of Florida)
Login to view more data
100 Deals associated with pp65 fl LAMP mRNA-LPs Vaccine(University of Florida)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Phase 2 | United States | 09 Aug 2016 | |
| Glioblastoma Multiforme | Phase 2 | United States | 09 Aug 2016 | |
| Recurrent Glioblastoma | Phase 1 | United States | 02 Dec 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 175 | GM-CSF (Arm 1: pp65-shLAMP DC With GM-CSF and Td) | sqnkemhfvj(euzbilrfet) = mmyejstkvb ezgeiwlgze (vfsccgwhjr, qresleowrm - vflwnyjhfp) View more | - | 14 Jan 2025 | ||
pp65-flLAMP DC (Arm 2: pp65-flLAMP DC With GM-CSF and Td) | sqnkemhfvj(euzbilrfet) = drctbwjcfb ezgeiwlgze (vfsccgwhjr, lkmjpbdoih - fawvrsxpgx) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free